Trefoil Therapeutics, Inc. — Form D
Trefoil Therapeutics, Inc. of El Cajon, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-22. The offering totals $12.0M, of which $12.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-03-22
- Form: D
- Accession: 0001691855-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $12.0M
- Remaining: $29K
- Investors: 14
- Date of first sale: 2022-03-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-438338
Issuer
- Name: Trefoil Therapeutics, Inc.
- CIK: 0001691855
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: c/o Dodson and Dodson, El Cajon, CA, 92021
- Phone: 917-628-8502
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| David Eveleth | Director | San Diego, CA |
| Derek Yoon | Director | Boston, MA |
| David Eveleth | Executive Officer | San Diego, CA |
| Schalon Newton | Executive Officer | San Diego, CA |
| Christy Shaffer | Director | Durham, NC |
| Stella Robertson | Director | El Cajon, CA |
| Jonathan Mow | Executive Officer | El Cajon, CA |
| Ben McGraw | Director | El Cajon, CA |
| John Fucci | Director | El Cajon, CA |
| Kseniya Simpson | Director | El Cajon, CA |
| Ralph Bradshaw | Director | San Diego, CA |
Other filings by this issuer (4)
More